Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Autor: Freijat, Faraj Al, Sheikh, Waad Al, Alizon, Claire, Amrane, Karim, Auliac, Jean-Bernard, Auvray, Etienne, Banciu, Nicolae, Bedossa, Alexandra, Belhaj, Issam, Belle, Antoine, Belmont, Laure, Benmammar, Kheir Eddine, Bernardi, Marie, Beynel, Pascal, Bigot, Fréderic, Bizieux-Thaminy, Acya, Blanchet-Legens, Anne-Sophie, Bonnefoy, Philippe, Bordier, Soraya, Bravard, Anne-Sophie, Briens, Éric, Brun, Philippe, Bugnet, Anne-Sophie, Bylicki, Olivier, Chablais, Laetitia, Chiappa, Anne-Marie, Chikouche, Reda, Christiann, François, Clarot, Caroline, Corre, Romain, Courdeau-Labourie, Joelle, Crequit, Jacky, Dayen, Charles, De chabot, Gonzague, Debieuvre, Didier, Decroisette, Chantal, Dehette, Stéphanie, Delafosse, Christian, Delclaux, Bertrand, Delmas, Christina, Demontrond, Pierre, Dot, Jean-Marc, Dujon, Cécile, Dumont, Patrick, Dussopt, Christine, Duval, Fatima, Khanjari, Fethi El, Falchero, Lionel, Fouet, Kevin, Francois, Hugues, Ghalloussi-Tebai, Yannick, Goarant, Éric, Godbert, Benoît, Goupil, François, Haouachi, Rym, Hauss, Pierre-Alexandre, Jaafar, Mohamad, Jarjour, Baihas, Jeandeau, Serge, Julien, Sylvie, Kraemer, Jean Philippe, Kuntz, Pierre, Lamotte, Florence, Larive, Sébastien, Laurent, Thomas, Floch, Hervé Le, Garff, Gwenaëlle Le, Treut, Jacques Le, Lecuyer, Emmanuelle, Lefoll, Christine, Leleu, Olivier, Doubliez, Marguerite Lepoulain, Levrat, Virginie, Locher, Chrystèle, Loutski-Vettese, Sandrine, Maetz, Edith, Magne, Fanny, Maincent, Cécile, Mairovitz, Alexa, Marichy, Catherine, Marion, Nancy, Marquette, David, Martignac, Bénédicte, Martinez, Stéphanie, Marty, Clothilde, Masson, Philippe, Maurer, Cyril, Meniai, Vincent, De Faverges, Geoffroy Milliet, Molinier, Olivier, Monnet, Isabelle, Moreau, Lionel, Morel, Hugues, Mosser, Laurent, Neidhardt, Anne-Catherine, Nunes, David, Obert, Julie, Pante, Vanessa, Paysse, Magalie, Pegliasco, Herve, Peloni, Jean-Michel, Perrin, Christophe, Petit, Lidia, Picaud, Marjorie, Pinsolle, Julian, Popa, Mihai, Portel, Laurent, Quieffin, Jean, Rabut, Hong, Redureau, Élise, Renault, David, Renault, Patrick Aldo, Rizzo, Claudia, Russier, Maud, Sabatini, Marielle, Saelens, Thierry, Schneider, Sophie, Slaouti, Philippe, Stoven, Luc, Tack, Vincent, Tavernier, Jean-Yves, Templement-Grangerat, Dorine, Thirard, Laurence, Thomassin, Séverine, Tiercin, Marie, Tredaniel, Jean, Tudor, Andreea, Turlotte, Amélie, Vincent, Colette, Virally, Jérôme, Meyer, Nicolas, Duval, Yannick, Asselain, Bernard, Letierce, Alexia, Trédaniel, Jean, Fore, Mathieu, Couraud, Sébastien, Cortot, Alexis

Publikováno v: In The Lancet Regional Health - Europe November 2022 22

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

Autor: Baize, Nathalie, Monnet, Isabelle, Greillier, Laurent, Geier, Margaux, Lena, Hervé, Janicot, Henri, Vergnenegre, Alain, Crequit, Jacky, Lamy, Regine, Auliac, Jean-Bernard, Letreut, Jacques, Le Caer, Hervé, Gervais, Radj, Dansin, Eric, Madroszyk, Anne, Renault, Patrick-Aldo, Le Garff, Gwenaëlle, Falchero, Lionel, Berard, Henri, Schott, Roland, Saulnier, Patrick, Chouaid, Christos ^*

Publikováno v: In The Lancet Oncology September 2020 21(9):1224-1233

Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study

Autor: Vergnenegre, Alain, Corre, Romain, Berard, Henri, Paillotin, Dominique, Dujon, Cecile, Robinet, Gilles, Crequit, Jacky, Bota, Suzanna, Thomas, Pascal, Chouaid, Christos

Publikováno v: In Journal of Thoracic Oncology January 2011 6(1):161-168

Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials

Autor: Peters, Solange Danson, Sarah Ejedepang, Dunson Dafni, Urania Hasan, Baktiar Radcliffe, Hoi-Shen Bustin, Frederique and Crequit, Jacky Coate, Linda Guillot, Monica Surmont, Veerle Rauch, Daniel Rudzki, Jakob O'Mahony, Deirdre and Aranda, Isidoro Barneto Scherz, Amina Tsourti, Zoi and Roschitzki-Voser, Heidi Pochesci, Alessia Demonty, Gaston and Stahel, Rolf A. O'Brien, Mary

Introduction: The efficacy of adding denosumab to standard first-line chemotherapy for advanced NSCLC patients has been evaluated in two separate randomised trials (SPLENDOUR and AMGEN-249). In this pooled analysis, we will assess the combination-tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::c5fedd88aa5eb9dd92b1cbf2d1e46f8e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3031559

Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)

Autor: Vergnenègre,Alain, Basse,Victor, Le Garff,Gwenaelle, Bylicki,Olivier, Dubos-Arvis,Catherine, Comet,Bénédicte, Marcq,Marie, Le Treut,Jacques, Auliac,Jean-Bernard, Madroszyk,Anne, Fraboulet,Gislaine, Crequit,Jacky, Thomas,Pascal, Paleiron,Nicolas, Monnet,Isabelle

Publikováno v: Cancer Management and Research.

Alain Vergnenègre,1 Victor Basse,2 Gwenaelle Le Garff,3 Olivier Bylicki,4 Catherine Dubos-Arvis,5 Bénédicte Comet,6 Marie Marcq,7 Jacques Le Treut,8 Jean-Bernard Auliac,9 Anne Madroszyk,10 Gislaine Fraboulet,11 Jacky Crequit,12 Pascal Thomas,13 Ni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dovemedicalp::28480adde842b99e2a0f39c21bff4b2f
https://www.dovepress.com/potential-antiangiogenic-treatment-eligibility-of-patients-with-squamo-peer-reviewed-article-CMAR